Systemic sclerosis is a chronic autoimmune disease of still not fully understood
pathogenesis. Fibrosis, vascular wall damage, and disturbances of innate and acquired …

OBJECTIVES: Interstitial lung disease (ILD) is currently the main cause of death in systemic
sclerosis (SSc) and has an unknown pathogenesis. Gastroesophageal reflux (GER) has …

INTRODUCTION: Previous studies of interstitial lung disease (ILD) suggest that prognosis
and therapeutic response are influenced by the presence of underlying collagen vascular …

Objective We sought to determine the effectiveness of mycophenolate mofetil (MMF) in
scleroderma-associated interstitial lung disease (SSc-ILD). Methods We retrospectively …

Up to 80% of patients with scleroderma have lung disease, with interstitial lung disease
(ILD) being the most common manifestation. Currently, there is no definitive therapy for this …

Animal Lectins: Form, Function and Clinical Applications presents up-to-date knowledge of
animal lectins. Detailed descriptions on biological activities, tissue and/or subcellular …

Objectives To evaluate the clinical characteristics of patients with interstitial lung disease
(ILD) in the setting of a large cohort of systemic sclerosis (SSc) patients, and to analyse the …

The wide-ranging effects of connective tissue diseases create a significant challenge for the
perioperative physician. Multisystem involvement, treatmentrelated organ dysfunction and a …

Purpose: To evaluate high-resolution CT (HRCT) parameters of inflammation and fibrosis in
systemic sclerosis (SSc), for correlation with lung function, skin scores and exercise …

Microscopic polyangiitis (MPA) may present with a syndrome that resembles idiopathic
pulmonary fibrosis (IPF). We describe an MPA patient with the clinical presentation of a …